T2	Drug 114 124	medication
E2	Drug:T2 
T3	And 125 128	and
E3	And:T3 Arg:E2 Arg2:E1
T4	Drug 143 162	dietary supplements
E4	Drug:T4 Name:T22
T6	Negation 191 193	no
E6	Negation:T6 Negates:E7 Negates2:E9
T7	Condition 194 218	blood clotting disorders
E7	Condition:T7 Name:T23
T8	Or 219 221	or
E8	Or:T8 Arg:E7 Arg2:E9
T9	Condition 222 235	dyslipidaemia
E9	Condition:T9 Name:T24
T10	Condition 274 292	clotting disorders
E10	Condition:T10 Name:T25
T11	Condition 294 306	dyslipidemia
E11	Condition:T11 Name:T26
T12	Or 307 309	or
E12	Or:T12 Arg:E11 Arg2:E14
T13	Eq-Comparison 316 318	on
E13	Eq-Comparison:T13 Temporal-Period:T27
T14	Drug 319 329	medication
E14	Drug:T14 Temporality:E13
T15	Drug 336 343	statins
E15	Drug:T15 Name:T28
T16	Or 345 347	or
E16	Or:T16 Arg:E15 Arg2:E18
T17	Other 348 353	other
E17	Other:T17 Is-Other:E18
T18	Drug 354 365	supplements
E18	Drug:T18 Name:T29
T19	Temporal-Connection 366 372	during
E19	Temporal-Connection:T19 Arg:E18 Arg2:E20
A3	Temporal-Connection-Type-Value E19 during
T20	Study 377 382	study
E20	Study:T20 
T21	Negation 391 399	excluded
E21	Negation:T21 Negates:E20
T22	Drug-Name 143 162	dietary supplements
T23	Condition-Name 194 218	blood clotting disorders
T24	Condition-Name 222 235	dyslipidaemia
T25	Condition-Name 274 292	clotting disorders
T26	Condition-Name 294 306	dyslipidemia
T27	Eq-Temporal-Period 316 318	on
A4	Eq-Temporal-Period-Value T27 present
T28	Drug-Name 336 343	statins
T29	Drug-Name 354 365	supplements
T30	Negation 110 113	off
E22	Negation:T30 Negates:E2
T1	Negation 129 132	off
E1	Negation:T1 Negates:E4
T5	And 236 239	and
E5	And:T5 Arg:E9 Arg2:E10
R1	Example-Of Arg1:E15 Arg2:E14	
